Wolverine Asset Management’s Calumet Specialty Products CLMT Stock Holding History

Wolverine Asset Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-30	Closed	-$1K	–	2482
2013 Q4	$1K	Buy	+30	New	+$838	﹤0.01%	2562
2013 Q3	–	Sell	-52	Closed	-$7K	–	2695
2013 Q2	$7K	Buy	+52	New	+$1.87K	﹤0.01%	2288

Other funds holding CLMT

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

SCM

Springhouse Capital Management Westport, Connecticut $55.3M AUM 20.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

WWM

Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

Wolverine Asset Management's CLMT Position: Q2 2014 in Review

Wolverine Asset Management sold out of Calumet Specialty Products (CLMT) in Q2 2014, closing a stake of 5,100 shares — an estimated $131K sold.

Wolverine Asset Management first reported a position in CLMT in Q2 2013 and held it in 4 quarters. The position peaked at $257K in Q4 2013. 124 funds tracked by Wall St. Rank hold CLMT as of Q2 2014.

Wolverine Asset Management reported no remaining Calumet Specialty Products position as of Q2 2014 after selling out during the quarter.
Wolverine Asset Management sold 5,100 Calumet Specialty Products shares in Q2 2014, an estimated $131K.
Wolverine Asset Management first reported a position in Calumet Specialty Products in Q2 2013 and held it in 4 quarters.
Wolverine Asset Management's Calumet Specialty Products position peaked at $257K in Q4 2013.
124 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2014.

Based on Wolverine Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.